Cancer
Conditions
Interventions
None listed
Sponsors
National Cancer Center Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients with histologically or cytologically diagnosed solid tumors (malignant tumors) 2) Patients who are 18 years of age or older at the time of registration 3) Patients who are or may be diagnosed and treated at the National Cancer Center Hospital 4) Patients for whom one or more of the following tumor tissues can be obtained (however, patients referred from other hospitals and who bring/provide their own tissues at the time of referral are also eligible for use). Tumor tissue (1) Surplus tissue from tumors removed during surgery (including some non-tumor tissue) 2) Surplus tissue of biopsy specimens collected or to be collected for diagnostic or medical use 5) Patients for whom one or more of the following non-tumor tissues can be obtained (however, patients referred from other hospitals and tissues brought or provided at the time of referral, etc., can also be used.) Non-tumor tissue (1) Blood samples collected after consent for this study (2) Excess non-tumor specimens (other than blood specimens) collected for medical treatment after consent for this study 3) Normal tissues (skin, hair follicles, oral mucosa, bone marrow, etc.), body cavity fluid (pleural fluid, ascites fluid, etc.), spinal fluid, excretory products (urine, stool), etc. 6) Patients who have given written informed consent to participate in this study. If the patient is a minor, the consent of a surrogate (parent or legal guardian) must be obtained.
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The construction of a method for isolation and identification of CTC. Clinical application of CTC. | — |
Countries
Japan
Contacts
Public ContactTakafumi Koyama
National Cancer Center Hospital Department of Experimental Therapeutics
Outcome results
None listed